6.
Luevano M, Domogala A, Blundell M, Jackson N, Pedroza-Pacheco I, Derniame S
. Frozen cord blood hematopoietic stem cells differentiate into higher numbers of functional natural killer cells in vitro than mobilized hematopoietic stem cells or freshly isolated cord blood hematopoietic stem cells. PLoS One. 2014; 9(1):e87086.
PMC: 3906137.
DOI: 10.1371/journal.pone.0087086.
View
7.
Michel T, Poli A, Cuapio A, Briquemont B, Iserentant G, Ollert M
. Human CD56bright NK Cells: An Update. J Immunol. 2016; 196(7):2923-31.
DOI: 10.4049/jimmunol.1502570.
View
8.
Nielsen C, White M, Goodier M, Riley E
. Functional Significance of CD57 Expression on Human NK Cells and Relevance to Disease. Front Immunol. 2013; 4:422.
PMC: 3856678.
DOI: 10.3389/fimmu.2013.00422.
View
9.
Pende D, Falco M, Vitale M, Cantoni C, Vitale C, Munari E
. Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation. Front Immunol. 2019; 10:1179.
PMC: 6558367.
DOI: 10.3389/fimmu.2019.01179.
View
10.
Sarvaria A, Jawdat D, Madrigal J, Saudemont A
. Umbilical Cord Blood Natural Killer Cells, Their Characteristics, and Potential Clinical Applications. Front Immunol. 2017; 8:329.
PMC: 5362597.
DOI: 10.3389/fimmu.2017.00329.
View
11.
Satwani P, van de Ven C, Ayello J, Cairo D, Simpson L, Baxi L
. Interleukin (IL)-15 in combination with IL-2, fms-like tyrosine kinase-3 ligand and anti-CD3 significantly enhances umbilical cord blood natural killer (NK) cell and NK-cell subset expansion and NK function. Cytotherapy. 2011; 13(6):730-8.
DOI: 10.3109/14653249.2011.563292.
View
12.
Shah N, Martin-Antonio B, Yang H, Ku S, Lee D, Cooper L
. Antigen presenting cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer cells with anti-myeloma activity. PLoS One. 2013; 8(10):e76781.
PMC: 3800010.
DOI: 10.1371/journal.pone.0076781.
View
13.
Shimasaki N, Jain A, Campana D
. NK cells for cancer immunotherapy. Nat Rev Drug Discov. 2020; 19(3):200-218.
DOI: 10.1038/s41573-019-0052-1.
View
14.
Souza-Fonseca-Guimaraes F, Cursons J, Huntington N
. The Emergence of Natural Killer Cells as a Major Target in Cancer Immunotherapy. Trends Immunol. 2019; 40(2):142-158.
DOI: 10.1016/j.it.2018.12.003.
View
15.
Strauss-Albee D, Horowitz A, Parham P, Blish C
. Coordinated regulation of NK receptor expression in the maturing human immune system. J Immunol. 2014; 193(10):4871-9.
PMC: 4225175.
DOI: 10.4049/jimmunol.1401821.
View
16.
Valipour B, Abedelahi A, Naderali E, Velaei K, Movassaghpour A, Talebi M
. Cord blood stem cell derived CD16 NK cells eradicated acute lymphoblastic leukemia cells using with anti-CD47 antibody. Life Sci. 2019; 242:117223.
DOI: 10.1016/j.lfs.2019.117223.
View
17.
Vitale C, Cottalasso F, Montaldo E, Moretta L, Mingari M
. Methylprednisolone induces preferential and rapid differentiation of CD34+ cord blood precursors toward NK cells. Int Immunol. 2008; 20(4):565-75.
DOI: 10.1093/intimm/dxn014.
View
18.
Vosshenrich C, Ranson T, Samson S, Corcuff E, Colucci F, Rosmaraki E
. Roles for common cytokine receptor gamma-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo. J Immunol. 2005; 174(3):1213-21.
DOI: 10.4049/jimmunol.174.3.1213.
View
19.
White M, Nielsen C, McGregor R, Riley E, Goodier M
. Differential activation of CD57-defined natural killer cell subsets during recall responses to vaccine antigens. Immunology. 2014; 142(1):140-50.
PMC: 3992055.
DOI: 10.1111/imm.12239.
View
20.
Zare M, Valipour B, Mohammadi S, Nouri M, Movassaghpour A, Nozad Charoudeh H
. Rapamycin Inhibits Expansion of Cord Blood Derived NK and T Cell. Iran J Immunol. 2017; 14(3):192-199.
DOI: IJIv14i3A2.
View